Biotech Showcase 2018

The 2018 Biotech Showcase will be held January 8-10, 2018 in San Francisco, California.

The event is considered a critical strategic benchmark for business development activities and one of the year’s most important investor conferences.

Numerous one-to-one meetings, company presentations and networking opportunities drive the Biotech Showcase. Meet with hundreds of investors, including institutional, private equity, angel and venture investors in search of innovative life sciences and biotech companies.

Highlighted workshops and panels include:

• The microbiome: Beyond the gut
• Next-Generation CARS and other cell-based immunotherapies
• Gene therapy: The outlook beyond rare disease
• Biotechnology and life sciences at a tipping point
• Public markets and biotech: What to expect in 2018
• The metabolic syndrome epidemic
• Infectious disease in the age of resistance
• What it means to be in the era of cures
• Data as the new rocket fuel for healthcare investing
• Drivers of innovation: Evolving models in rare disease drug development
• Analyst’s pulse: What’s hot and what’s not
• IO on the move: New targets, trends and combinations
• What’s behind the 2017 record-breaking venture numbers?
• Media roundup: Heard around the square

Last year’s Biotech Showcase drew more than 1800 companies and 900+ investors.

The event coincides with the 2018 invitation-only JP Morgan Annual Healthcare Conference being held at the nearby Westin St. Francis.

Please visit the EBD Group’s 2018 Biotech Showcase website for more information.